ArticleCirculation reports2026
Interfacility Transfer and Mortality in Patients With Type A Acute Aortic Dissection - Analysis of the Tokyo Acute Aortic Super-Network Database.
Article in Circulation reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The aortic window: a temporal framework for acute type A aortic dissection.Annals of cardiothoracic surgery · 2026Article
- Reperfusion Therapy and Outcomes in High-Risk Pulmonary Embolism: Multicenter Registry Study From the Tokyo Cardiovascular Care Unit Network.Circulation reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Type A acute aortic dissection (TAAAD) requires integrated care and often interfacility transfer. However, the association between transfer and outcome remains unclear. Methods and Results: We analyzed 328 patients with TAAAD who were admitted within 48 h of onset and were enrolled in the Tokyo Acute Aortic Super-Network Database between November 2010 and October 2011. Patients with intramural hematoma, cardiopulmonary arrest before arrival, or those who refused surgery were excluded. Directly admitted patients who underwent fewer operations were more often treated at lower-volume institutes and experienced higher rates of respiratory failure and renal ischemia, with a shorter time from symptom onset to admission, than transferred patients. The 30-day mortality rate was higher in directly admitted patients (n=182) than in transferred patients (n=146; 25.8% vs. 14.4%; P=0.016). Logistic regression analysis identified age (odds ratio [OR] 1.05; 95% confidence interval [CI] 1.01-1.09; P=0.025), pre-arrival complications (OR 3.09; 95% CI 1.40-6.86; P=0.005), and surgery (OR 0.084; 95% CI 0.031-0.23; P<0.001) as independent predictors of 30-day mortality, while transfer status was not predictive (OR 0.836; 95% CI 0.345-2.02; P=0.69). Conclusions: Interfacility patient transfer did not appear to affect early mortality in patients with TAAAD; however, large scale studies are warranted to confirm this finding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.